第XIII因子
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
- 1. 稀な遺伝性凝固異常rare inherited coagulation disorders [show details]
…Factor XIII deficiency (F13D; OMIM 613225 or OMIM 613235) – The factor XIII enzyme is a heterotetramer consisting of two catalytic A subunits and two B subunits . Most reported cases of factor XIII deficiency …
- 2. 出血症状を有する小児に対するアプローチapproach to the child with bleeding symptoms [show details]
…of factor XIII . However, the clot solubility assay is sensitive only at very low levels (factor XIII 1 to 3 percent) and may miss the diagnosis in less severe cases. Therefore, if factor XIII deficiency …
- 3. 血漿分画製剤および組換えDNA産生凝固因子plasma derivatives and recombinant dna produced coagulation factors [show details]
… Factor XIII or factor X products can be used to treat bleeding or prevent surgical bleeding in individuals with inherited deficiencies of factor XIII or factor X, respectively. Factor XIII (and occasionally …
- 4. 後天性の凝固因子阻害物質acquired inhibitors of coagulation [show details]
…factor XIII stabilizes and crosslinks overlapping fibrin strands. Factor XIII inhibitors, which are exceedingly rare, can act by one of several mechanisms: inhibition of activation of factor XIII; interference …
- 5. 心因性紫斑病(ガードナーダイヤモンド症候群)psychogenic purpura gardner diamond syndrome [show details]
…mild VWD may be difficult to make, and may require serial testing. Congenital (or acquired) factor XIII deficiency is associated with normal PT and aPTT. The most commonly reported clinical symptoms include…
English Journal
- Development and Validation of a New Risk Prediction Score for Life-Threatening Ventricular Tachyarrhythmias in Laminopathies.
- Wahbi K, Ben Yaou R, Gandjbakhch E, Anselme F, Gossios T, Lakdawala NK, Stalens C, Sacher F, Babuty D, Trochu JN, Moubarak G, Savvatis K, Porcher R, Laforêt P, Fayssoil A, Marijon E, Stojkovic T, Béhin A, Leonard-Louis S, Sole G, Labombarda F, Richard P, Metay C, Quijano-Roy S, Dabaj I, Klug D, Vantyghem MC, Chevalier P, Ambrosi P, Salort E, Sadoul N, Waintraub X, Chikhaoui K, Mabo P, Combes N, Maury P, Sellal JM, Tedrow UB, Kalman JM, Vohra J, Androulakis AFA, Zeppenfeld K, Thompson T, Barnerias C, Bécane HM, Bieth E, Boccara F, Bonnet D, Bouhour F, Boulé S, Brehin AC, Chapon F, Cintas P, Cuisset JM, Davy JM, De Sandre-Giovannoli A, Demurger F, Desguerre I, Dieterich K, Durigneux J, Echaniz-Laguna A, Eschalier R, Ferreiro A, Ferrer X, Francannet C, Fradin M, Gaborit B, Gay A, Hagège A, Isapof A, Jeru I, Morales RJ, Lagrue E, Lamblin N, Lascols O, Laugel V, Lazarus A, Leturcq F, Levy N, Magot A, Manel V, Martins R, Mayer M, Mercier S, Meune C, Michaud M, Minot-Myhié MC, Muchir A, Nadaj-Pakleza A, Péréon Y, Petiot P, Petit F, Praline J, Rollin A, Sabouraud P, Sarret C, Schaeffer S, Taithe F, Tard C, Tiffreau V, Toutain A, Vatier C, Walther-Louvier U, Eymard B, Charron P, Vigouroux C, Bonne G, Kumar S, Elliott P, Duboc D.
- Circulation. 2019 Jun;().
- An accurate estimation of the risk of life-threatening (LT) ventricular tachyarrhythmia (VTA) in patients with LMNA mutations is crucial to select candidates for implantable cardioverter defibrillator (ICD) implantation. We included 839 adult patients with LMNA mutations, including 660 from a French
- PMID 31155932
- Factor XIII Prevents Pulmonary Emboli in Mice by Stabilizing Deep Vein Thrombi.
- Shaya SA, Gani DM, Weitz JI, Kim PY, Gross PL.
- Thrombosis and haemostasis. 2019 Jun;119(6)992-999.
- Deep vein thrombosis (DVT) can lead to pulmonary embolism (PE), but the mechanisms responsible for this progression are unknown. Previously, we showed that inhibition of thrombin-mediated activation of factor (F) XIII promotes venous thrombus stability in a murine model. In this study, we inve
- PMID 31005064
- Convergence of Bigelow and Arrhenius models over a wide range of heating temperatures.
- André S, Leguerinel I, Palop A, Desriac N, Planchon S, Mafart P.
- International journal of food microbiology. 2019 Feb;291()173-180.
- The heat resistance of the bacterial spores of Moorella thermoacetica, Clostridium sporogenes, Geobacillus stearothermophilus and Bacillus coagulans was determined over a wide range of temperatures using the capillary method and thermoresistometer Mastia. The results showed that the two experimental
- PMID 30508773
Japanese Journal
- 書評 Christopher W. Miller, Planning and Profits : British Naval Armaments Manufacture and the Military-Industrial Complex, 1918-1941 (Liverpool, Liverpool University Press, 2018), ⅹⅲ+246pp.
- 横井 勝彦
- 国際武器移転史 : The journal of Research Institute for the History of Global Arms Transfer (7), 87-90, 2019-01
- NAID 120006594869
- 日本社会臨床学会第XIII期中間総括(2017年4月〜2018年3月)
- 新規D-dimer試薬LPIAジェネシスDダイマーの基礎性能評価および試薬特性
- 下仮屋 雄二,渡邊 真希,坂口 茜,西川 美有,秋月 基伸,桜井 錠治,森本 誠,中谷 中
- 医学検査 68(1), 85-91, 2019
- … 凝固第XIII因子欠乏血漿を凝固させた後に線溶させた結果,経過時間に伴う測定値の上昇を認めるがACE-DDより低値であった。 …
- NAID 130007557519
Related Links
- FINAL FANTASY XIII 本サイトのご利用にあたって ご使用のブラウザ環境では、本コンテンツが正しく表示できない可能性があります。下記の注意点を確認し、必要な設定を行った上でブラウザを再起動してください。 ブラウザの JavaScript ...
- Moved Permanently. The document has moved here.
- PS3「FF13(ファイナルファンタジー13)」を攻略します。
★リンクテーブル★
[★]
- 英
- factor XIII, F XIII
- 同
- フィブリン安定化因子, fibrin-stabilizing factor, fibrin stabilizing factor, FSF、血漿トランスグルタミナーゼ, plasma transglutaminase、血液凝固第XIII因子、凝固第XIII因子
- 商
- フィブロガミンP
- 関
- 血液凝固因子
- トロンビンにより活性化され、フィブリン線維を架橋してフィブリン網を安定化させる血液凝固因子の一つ。
臨床関連
低下
[★]
- 英
- aprotinin
- 関
- セリンプロテアーゼ、セリンプロテアーゼ阻害薬
[★]
フェニルアラニン phenylalanine